The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo.
- DOI
- 10.1016/j.expneurol.2026.116015
- Published
- 2026 Sep 18
- Container
- Experimental neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.expneurol.2026.116015,
title = {The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo.},
author = {Totta-Griese G and Enders JD and Madden TK and Ryals J and Hurd RE and Crowards S and Hauser W and Heslop LL and Manning A and West L and Morris J and Wright DE},
year = {2026},
journal = {Experimental neurology},
doi = {10.1016/j.expneurol.2026.116015},
url = {https://doi.org/10.1016/j.expneurol.2026.116015}
}RIS
TY - JOUR TI - The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo. AU - Totta-Griese G AU - Enders JD AU - Madden TK AU - Ryals J AU - Hurd RE AU - Crowards S AU - Hauser W AU - Heslop LL AU - Manning A AU - West L AU - Morris J AU - Wright DE PY - 2026 JO - Experimental neurology DO - 10.1016/j.expneurol.2026.116015 UR - https://doi.org/10.1016/j.expneurol.2026.116015 ER -
APA
G, T., JD, E., TK, M., J, R., RE, H., S, C., W, H., LL, H., A, M., L, W., J, M., & DE, W. (2026). The glycolytic metabolite methylglyoxal drives axon degeneration in vitro and in vivo.. Experimental neurology. https://doi.org/10.1016/j.expneurol.2026.116015
Source records
- pubmed · retrieved 2026-09-26T03:57:13.775Z